TGFB1 and Hyperglycemia: Moreover, in vitro experiments revealed that Tanshinone IIA, one of the components of SM, inhibits hyperglycemia-driven apoptosis and inflammation of renal tubule epithelial cells by the modulation of transforming growth factor β1 (TGF-β1) (Li et al., 2022b).